Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

Rare long-term survivors of pancreatic adenocarcinoma without curative resection.

Oh SY, Edwards A, Mandelson MT, Lin B, Dorer R, Helton WS, Kozarek RA, Picozzi VJ.

World J Gastroenterol. 2015 Dec 28;21(48):13574-81. doi: 10.3748/wjg.v21.i48.13574.

2.

Improving Survival of Pancreatic Cancer. What Have We Learnt?

Singh T, Chaudhary A.

Indian J Surg. 2015 Oct;77(5):436-45. doi: 10.1007/s12262-015-1368-7. Epub 2015 Oct 22.

PMID:
26722209
3.

Vascular Resection in Pancreatic Cancer.

Luketina RR, Hackert T, Büchler MW.

Indian J Surg. 2015 Oct;77(5):381-6. doi: 10.1007/s12262-015-1364-y. Epub 2015 Oct 14.

PMID:
26722200
4.

Evolution of cellular morpho-phenotypes in cancer metastasis.

Wu PH, Phillip JM, Khatau SB, Chen WC, Stirman J, Rosseel S, Tschudi K, Van Patten J, Wong M, Gupta S, Baras AS, Leek JT, Maitra A, Wirtz D.

Sci Rep. 2015 Dec 17;5:18437. doi: 10.1038/srep18437.

5.

Current State of Vascular Resections in Pancreatic Cancer Surgery.

Hackert T, Schneider L, Büchler MW.

Gastroenterol Res Pract. 2015;2015:120207. doi: 10.1155/2015/120207. Epub 2015 Nov 2. Review.

6.

Resection of metachronous pancreatic cancer 4 years after pancreaticoduodenectomy for stage III pancreatic adenocarcinoma.

Hamner JB, White M, Crowder C, Singh G.

World J Surg Oncol. 2015 Sep 30;13:290. doi: 10.1186/s12957-015-0712-5.

7.

Effectiveness of plasma treatment on pancreatic cancer cells.

Hattori N, Yamada S, Torii K, Takeda S, Nakamura K, Tanaka H, Kajiyama H, Kanda M, Fujii T, Nakayama G, Sugimoto H, Koike M, Nomoto S, Fujiwara M, Mizuno M, Hori M, Kodera Y.

Int J Oncol. 2015 Nov;47(5):1655-62. doi: 10.3892/ijo.2015.3149. Epub 2015 Sep 7.

8.

Clinicopathological Significance of CDKN2A Promoter Hypermethylation Frequency with Pancreatic Cancer.

Tang B, Li Y, Qi G, Yuan S, Wang Z, Yu S, Li B, He S.

Sci Rep. 2015 Sep 4;5:13563. doi: 10.1038/srep13563.

9.

Prognostic Fifteen-Gene Signature for Early Stage Pancreatic Ductal Adenocarcinoma.

Chen DT, Davis-Yadley AH, Huang PY, Husain K, Centeno BA, Permuth-Wey J, Pimiento JM, Malafa M.

PLoS One. 2015 Aug 6;10(8):e0133562. doi: 10.1371/journal.pone.0133562. eCollection 2015.

10.

Very long-term survival in pancreatic cancer.

Molin MD, Wood LD.

Aging (Albany NY). 2015 Jun;7(6):360-1. No abstract available.

11.

Adjuvant radiotherapy and chemoradiation with gemcitabine after R1 resection in patients with pancreatic adenocarcinoma.

Habermehl D, Brecht IC, Bergmann F, Rieken S, Werner J, Büchler MW, Springfeld C, Jäger D, Debus J, Combs SE.

World J Surg Oncol. 2015 Apr 15;13:149. doi: 10.1186/s12957-015-0560-3.

12.

Clinical and pathological features of five-year survivors after pancreatectomy for pancreatic adenocarcinoma.

Kimura K, Amano R, Nakata B, Yamazoe S, Hirata K, Murata A, Miura K, Nishio K, Hirakawa T, Ohira M, Hirakawa K.

World J Surg Oncol. 2014 Nov 27;12:360. doi: 10.1186/1477-7819-12-360.

13.

Proteins associated with pancreatic cancer survival in patients with resectable pancreatic ductal adenocarcinoma.

Chen R, Dawson DW, Pan S, Ottenhof NA, de Wilde RF, Wolfgang CL, May DH, Crispin DA, Lai LA, Lay AR, Waghray M, Wang S, McIntosh MW, Simeone DM, Maitra A, Brentnall TA.

Lab Invest. 2015 Jan;95(1):43-55. doi: 10.1038/labinvest.2014.128. Epub 2014 Oct 27.

14.

Pathology handling of pancreatoduodenectomy specimens: Approaches and controversies.

Gómez-Mateo Mdel C, Sabater-Ortí L, Ferrández-Izquierdo A.

World J Gastrointest Oncol. 2014 Sep 15;6(9):351-9. doi: 10.4251/wjgo.v6.i9.351. Review.

15.

Current and future intraoperative imaging strategies to increase radical resection rates in pancreatic cancer surgery.

Handgraaf HJ, Boonstra MC, Van Erkel AR, Bonsing BA, Putter H, Van De Velde CJ, Vahrmeijer AL, Mieog JS.

Biomed Res Int. 2014;2014:890230. doi: 10.1155/2014/890230. Epub 2014 Jul 15. Review.

16.

Resectable carcinoma developing in the remnant pancreas 7 years and 10 months after distal pancreatectomy for invasive ductal carcinoma of the pancreas: report of a case.

Akabori H, Shiomi H, Naka S, Murakami K, Murata S, Ishida M, Kurumi Y, Tani T.

World J Surg Oncol. 2014 Jul 18;12:224. doi: 10.1186/1477-7819-12-224.

17.

Adjuvant chemoradiation for pancreatic cancer: what does the evidence tell us?

Chuong MD, Boggs DH, Patel KN, Regine WF.

J Gastrointest Oncol. 2014 Jun;5(3):166-77. doi: 10.3978/j.issn.2078-6891.2014.025. Review.

18.

Epigenetics and pancreatic cancer: pathophysiology and novel treatment aspects.

Neureiter D, Jäger T, Ocker M, Kiesslich T.

World J Gastroenterol. 2014 Jun 28;20(24):7830-48. doi: 10.3748/wjg.v20.i24.7830. Review.

19.

Stereotactic Body Radiation Therapy (SBRT) for Unresectable Pancreatic Carcinoma.

Stauder MC, Miller RC.

Cancers (Basel). 2010 Aug 9;2(3):1565-75. doi: 10.3390/cancers2031565.

20.

Adjuvant chemotherapy in elderly patients with pancreatic cancer.

Nagrial AM, Chang DK, Nguyen NQ, Johns AL, Chantrill LA, Humphris JL, Chin VT, Samra JS, Gill AJ, Pajic M; Australian Pancreatic Cancer Genome Initiative, Pinese M, Colvin EK, Scarlett CJ, Chou A, Kench JG, Sutherland RL, Horvath LG, Biankin AV.

Br J Cancer. 2014 Jan 21;110(2):313-9. doi: 10.1038/bjc.2013.722. Epub 2013 Nov 21.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk